"Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular (Wet) Age-related Macular Degeneration (AMD)"

Birmingham (2 Locations)

Phoenix (2 Locations)

Tucson (2 Locations)

Arcadia

Beverly Hills

Campbell

Fresno

Fullerton

La Jolla

Loma Linda

Mountain View

Oakland

Orange

Palm Desert

Sacramento

San Mateo

Santa Ana

Torrance

Westlake Village

Yorba Linda

Colorado Springs

Denver (2 Locations)

Bridgeport

New Haven

New London

Altamonte Springs

Boynton Beach

Fort Myers (2 Locations)

Jacksonville

Miami

Orlando (2 Locations)

Oscala

Palm Beach Gardens

Pensacola

Stuart

Tampa

Winter Haven

Augusta

‘Aiea

Glenview

Fort Wayne

Indianapolis

New Albany

Iowa City

Wichita

Louisville

New Orleans

Bangor

Portland

Baltimore (3 Locations)

Chevy Chase

Hagerstown

Boston (2 Locations)

Peabody

Ann Arbor

Battle Creek

Grand Rapids

Jackson

Southfield

Minneapolis

Rochester

Florissant

Kansas City

Springfield

St Louis

Missoula

Lincoln

Las Vegas

Portsmouth

Lawrenceville

Northfield

Toms River

Albuquerque

Albany

Brooklyn

Lynbrook

New York (6 Locations)

Rochester (2 Locations)

Slingerlands

Syracuse

Asheville

Charlotte

Raleigh

Winston-Salem

Cincinnati

Cleveland

Oklahoma City

Ashland

Portland (3 Locations)

Salem

Kingston

Philadelphia (3 Locations)

Pittsburgh (2 Locations)

West Mifflin

Columbia

Greenville

West Columbia

Rapid City

Nashville

Austin (3 Locations)

Dallas

Fort Worth (2 Locations)

Houston

McAllen

Odessa

San Antonio (2 Locations)

Tyler

Salt Lake City (2 Locations)

Burlington

Charlottesville

Fairfax

Richmond

Seattle

Madison (2 Locations)

Milwaukee

Calgary

Vancouver

Victoria

Halifax

London

Mississauga

Ottawa

Montreal (2 Locations)

Regina